2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

Potential adherence to treatment in gastroenterological patients

Горбенко, А. В., Skirdenko, Y. P., Николаев, Н. А., Livzan, M. A., Andreev, K. A., & Fedorin, M. M. (2021) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-192-8-134-141 · Cited by 1

Low-Density Lipoprotein Cholesterol and Mortality Risk in Elderly Patients Undergoing Valve Replacement Surgery: A Propensity Score Matching Analysis

Li, H.-B., Fu, B., Tan, T., Li, X., Wang, S., Wei, X., & Wang, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.842734 · Cited by 1

THE ROLE OF THE GENE OF THE SECOND PHASE OF THE XENOBIOTIC BIOTRANSFORMATION SYSTEM GSTP1 (ILE105VAL) IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Kostyushok, N. Y., Pavlyuchenko, I. I., Ivanova, L. A., & Prozorovskaya, Y. I. (2022) · Современные проблемы науки и образования · doi:10.17513/spno.31902 · Cited by 1

Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles

Arrobas, T., Guijarro, C., Campuzano, R., Piñero, M. R., Marcos, J. F. V., López, A. M. B., López, A. M., López, A. M., Donaire, J. A. G., Obaya, J. C., et al. (2023) · REC CardioClinics · doi:10.55783/rcmf.160106 · Cited by 8

NMR derived changes of lipoprotein particle concentrations related to impaired fasting glucose, impaired glucose tolerance, or manifest type 2 diabetes mellitus

Kalbitzer, T., Lobenhofer, K., Martin, S., Erlach, M. B., Kremer, W., & Kalbitzer, H. R. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01801-7 · Cited by 1

Associations of arterial hypertension and the severity of the course of a new coronavirus infection

Tuzovskaia, O. V., Evdokimova, N. E., Garbuzova, E. V., Khudiakova, A. D., & Логвиненко, И. И. (2023) · Ateroscleroz · doi:10.52727/2078-256x-2023-19-1-19-27 · Cited by 1

Effect of Low Fat and Low Cholesterol Diet Intervention on LDL Subgroups in Dyslipidemic Patients: Epidemiological Observational Study

MUTLUTÜRK, Ü. K., Çiçek, B., Bayram, F., & DOĞRUEL, F. (2023) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.1182426 · Cited by 1

Medicine Optimisation Using PCSK9 Monoclonal Antibodies (alirocumab and evolocumab) Concerning the European Atherosclerosis Society (EAS) of < 1.8 mmol/l LDL Cholesterol Target in a Secondary Care Lipid Clinic

Bolodeoku, J., Gbaa, T. T., Morris, K., & Whitehead, S. J. (2023) · British journal of healthcare and medical research · doi:10.14738/bjhmr.106.15955 · Cited by 1

Why and when should be lipoprotein(a) level measured?

Broncel, M., & Broncel, M. (2023) · Exploration of Cardiology · doi:10.37349/ec.2023.00015 · Cited by 1

PHYSIOTHERAPY EFFECTIVENESS FOR RIVER TRANSPORT WORKERS WITH PRECLINICAL CARDIOVASCULAR DISEASE

Miryutova, N. F., Minchenko, N. N., Samoilova, I. M., & Голосова, О. Е. (2024) · Bulletin of Medical Science · doi:10.31684/25418475-2024-1-45 · Cited by 1

Chronic heart failure associated genetic polymorphisms

Свеклина, Т. С., Борисович, Ш. С., Николаевна, К. С., Kozlov, V. A., Дмитриевна, О. П., & Konyaev, V. V. (2024) · Bulletin of the Russian Military Medical Academy · doi:10.17816/brmma609539 · Cited by 1

THE IMPACT OF COMBINATION LIPID-LOWERING THERAPY ON PARAMETERS OF LIPID AND MINERAL PROFILE IN PATIENTS WITH DYSLIPIDEMIA, ACUTE CORONARY SYNDROME, AND CHRONIC CORONARY SYNDROME

Shishkova, D. K., Sedykh, D. Y., Hryachkova, O. N., Gruzdeva, O. V., Кутихин, А. Г., & Кашталап, В. В. (2025) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2025-14-2-186-199 · Cited by 1

Epidemiology and Prevention

Halle, M., & Münzel, T. F. (2025) · Springer eBooks · doi:10.1007/978-3-662-70152-2_3 · Cited by 1

LIVER, NON-ALCOHOLIC FATTY LIVER DISEASE AND DYSLIPIDEMIA. IS THERE A CONNECTION?

Гималетдинова, И. А., AMIROV, N. B., & ABSALYAMOVA, L. R. (2020) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2020.13(6).68-74 · Cited by 1

Association of the increased circulating CD62LloCXCR4hi neutrophil count with carotid atherosclerosis

Dolgushin, I. I., Genkel, V. V., Baturina, I., Emelyanov, I. V., Savochkina, A. Y., & Иосифович, Ш. И. (2021) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-67 · Cited by 1

THE FIRST RESULTS OF THE CINDI PROJECT IN ALTAI KRAI

Lazareva, N. V., & Svanadze, N. K. (2021) · Bulletin of Medical Science · doi:10.31684/25418475_2021_2_22 · Cited by 1

Gene polymorphisms associated with lipid metabolism disorders in young adults with risk of sudden cardiac death

Kachnov, V. A., Kryukov, E. V., Николаевна, К. С., Кутелев, Г. Г., & Tyrenko, V. V. (2021) · Kazan medical journal · doi:10.17816/kmj2021-805 · Cited by 2

Mortality risk in older Japanese people based on self-reported dyslipidemia treatment and socioeconomic status: The JAGES cohort study

Katsuyama, Y., Kondo, K., Kojima, M., Kamiji, K., Ide, K., Iizuka, G., Muto, G., Uehara, T., Noda, K., & Ikusaka, M. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101779 · Cited by 1

Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study

Sanin, V., Schmieder, R. S., Ates, S., Schlieben, L. D., Wiehler, J., Sun, R., Decker, M., Sander, M., Holdenrieder, S., Kohlmayer, F., et al. (2022) · Medizinische Genetik · doi:10.1515/medgen-2022-2115 · Cited by 1

Epidemiología y carga de morbilidad y mortalidad en dislipidemias y aterosclerosis

Borrayo–Sánchez, G. (2021) · Cardiovascular and Metabolic Science · doi:10.35366/100785 · Cited by 1

Effect of hypertension on microcirculatory disorders in patients with rheumatoid arthritis

Shimanski, D. A., Ивановна, Н. И., Inamova, O. V., Lapin, S. V., Kholopova, I. V., Blinova, T. V., Маzing, A. V., Галкина, О. В., Anpilova, A., Иванович, Т. В., et al. (2022) · Regional blood circulation and microcirculation · doi:10.24884/1682-6655-2022-21-2-26-36 · Cited by 1

Management of Dyslipidemia after Stroke

Chang, Y., & Song, T. (2022) · Journal of the Korean Neurological Association · doi:10.17340/jkna.2022.3.1 · Cited by 1

DIFFERENCES IN THE CARDIOVASCULAR RISK FACTOR PROFILES IN PATIENTS WITH TRANSIENT GLOBAL AMNESIA AND TRANSIENT ISCHEMIC ATTACK

Ryabchenko, A. Y. (2023) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2023-4-64-72 · Cited by 1

Cardiopatía isquémica

de la Iglesia, J. L., Vázquez, C. P., & Gómez, M. M. (2023) · Actualización en Medicina de Familia · doi:10.55783/190602 · Cited by 1

Impact of Gender Differences and Glycated Haemoglobin on Atherosclerosis Risk in Type 2 Diabetic Patients from North Western Algeria

Bouragba, I., Boularbag, H., & Diaf, M. (2020) · Advanced Journal of Graduate Research · doi:10.21467/ajgr.8.1.51-57

Added Value of Modified Anderson–Wilkins Acuteness Score in Prognostication of Patients with Acute Myocardial Infarction

Serafimov, A., Taravari, H., Shehu, E., Kitanoski, D., Miftari, V., Georgievska‐Ismail, L., Kedev, S. A., & Vavlukis, M. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.5425

Risk factors in acute diabetic foot syndrome: analysis of 75 consecutive patients referred to a tertiary center in Modena, Italy

Maurantonio, M., Gabrielli, F., Castellano, C., Andrea, C., Andreoné, P., & Roncucci, L. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00035

ENTROPY-PROBABILISTIC ANALYSIS OF DRUG SAFETY ON THE EXAMPLE OF THERAPY WITH HYPOLIPIDEMIC DRUGS

Yashin, D. A., & Тырсин, А. Н. (2021) · Современные проблемы науки и образования · doi:10.17513/spno.30614

Juventud y salud cardiovascular: ¿Qué factores de riesgo debemos tener en cuenta para intervenir?

Lozada-Martínez, I., & Bolaño-Romero, M. (2021) · Ciencia e Innovación en Salud · doi:10.17081/innosa.117

Lipids Abnormality and Type 2 Diabetes Mellitus: Causes and Consequences

Wang, K., & Ahmadizar, F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96592

Changes in plasma sphingolipid levels against the background of lipid-lowering therapy in patients with premature atherosclerosis

Rogozhina, A., Alessenko, A. V., Kurochkin, I. N., Minushkina, L. O., Гутнер, У. А., Shupik, M. A., Maloshitskaya, O., Lebedev, А. T., & Zateyshchikov, D. A. (2021) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2021.030

Immediate and long-term results of stenting of vertebral arteries in patients with asymptomatic chronic brain ischemia

Shugushev, Z. K., Karasev, S. M., Maximkin, D. A., & Chepurnoj, A. G. (2021) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2021-10-2-47-59

Carotid total plaque area as a marker of asymptomatic lower extremity arterial disease

Genkel, V. V., Иосифович, Ш. И., Лебедев, Е. В., & Salashenko, A. O. (2021) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2021-2-2-56-61

Role of bioactive lipids in metabolism of obese patients and prospects for their use in the postoperative period

А.Б., Ф., Ospanov, O. B., & Fursov, R. (2021) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20210302

Clinical decision support system for lipid metabolism disorders: relevance and potential

Alieva, A. S., Pavlyuk, E. I., Alborova, E. M., Звартау, Н. Э., Конради, А. О., Катапано, А., & Shlyakhto, E. V. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4539

Tratamiento con estatinas. La evidencia y el papel en la prevención primaria y secundaria

Morales-Villegas, E., & Ray, K. K. (2021) · Cardiovascular and Metabolic Science · doi:10.35366/100800

Different types of dyslipidemia in type 2 diabetes and the associated factors

Keskinler, M. V., & Oğuz, A. (2021) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.918697

Complex correction of metabolic changes and endothelial dysfunction in patients with ischemic heart disease and eff ort angina of functional class II

Дзугкоев, С. Г., Garmash, O. Y., Дзугкоева, Ф. С., Margieva, O. I., & Mozhaeva, I. V. (2021) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2021-99-4-266-271

Lipid-lowering therapy in special situations

Ватутин, Н. Т., Тарадин, Г. Г., Rakitskaya, I. V., Kharchenko, A. V., Stekhina, K. V., Linnik, I. G., Борт, Д. В., Гасендич, Е. С., & Mogilevskaya, K. E. (2021) · Health Food & Biotechnology · doi:10.36107/hfb.2020.i4.s88

Logical-linguistic Model of Risks of the Cardiovascular System

Gorbunov, A., Abbas, S. F., & Loktev, A. (2021) · International Conference on Control Systems, Mathematical Modeling, Automation and Energy Efficiency (SUMMA) · doi:10.1109/summa53307.2021.9632088

FADS1 genetic variant rs174547 as a molecular-genetic biomarker for CVD risk: A study from Bulgaria

Kuzova, E., Georgieva, T., & Duleva, V. L. (2021) · Hrana i ishrana · doi:10.5937/hraish2101015k

High-density lipoprotein cholesterol — friend or enemy?

Murzakhanova, A. F., OSLOPOV, V. N., Sergienko, K. S., Khazova, E. V., & OSLOPOVA, J. V. (2022) · Kazan medical journal · doi:10.17816/kmj2022-79

Tratamiento actual más allá de las estatinas en la hipercolesterolemia: cuanto más bajo mejor en la prevención de las enfermedades ateroscleróticas

Gómez-Álvarez, E., Chauvet, A. A., & Hernández‐Flores, K. R. (2021) · Cardiovascular and Metabolic Science · doi:10.35366/100801

Risk factors in acute diabetic foot syndrome: analysis of 75 consecutive patients referred to a tertiary center in Modena, Italy

Maurantonio, M., Gabrielli, F., Castellano, C., Andrea, C., Andreoné, P., & Roncucci, L. (2021) · Exploration of Medicine · doi:10.37349/emed.2020.00035

Experience with non-drug strategies in women with metabolic syndrome during the menopausal transition: a focus on cardiovascular risk

(2021) · Asia-Pacific Journal of Pharmacotherapy & Toxicology · doi:10.32948/ajpt.2021.03.10

Medical treatment of dyslipidemia in the elderly

Kim, H. J., & Kim, C. K. (2022) · Journal of Geriatric Neurology · doi:10.53991/jgn.2022.00129

Skin manifestations of secondary dyslipidemia: a case report

KIM, Z. F., Galyavich, A. S., Nurieva, L. M., & Bayazova, N. I. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5133

A STUDY ON THE OUTCOME OF COMBINATION THERAPY OF ASPIRIN AND ATORVASTATIN IN IMPROVEMENT OF ANKLE BRACHIAL PRESSURE INDEX AMONG PATIENTS WITH PERIPHERAL VASCULAR DISEASE IN A TERTIARY CARE CENTRE, SOUTH KERALA

Immanuel, P. A., Naraintran, S., Madhumitha., M., Sandeep, K. S., & Oli, P. T. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/4108475

Dietary and Physiological Factors Affecting Lipid Metabolism and Cardiovascular Risk

Yoshida, H. (2022) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.68.s119

Síndrome coronario crónico

Velásquez-Zapata, L., Díaz-Pérez, Y., Varleta, P. E., & Mónica Acevedo, B. (2022) · Cardiovascular and Metabolic Science · doi:10.35366/108052

Investigation on postprandial triglyceride and remnant-like particle cholesterol levels after low-fat meal ingestion in the Japanese population

Moriyama, K., Masuda, Y., Suzuki, N., Yamada, C., Kishimoto, N., Takashimizu, S., Akira, K. U. B. O., & Nishizaki, Y. (2022) · Health Evaluation and Promotion · doi:10.7143/jhep.2022-20

sST2 protein in working persons, its relationship with functional and biochemical markers of cardiovascular risk

Blinova, T. V., Strakhova, L. A., Александровна, У. И., Владимирович, Т. В., & Ivanova, Y. V. (2022) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin20221703151

STUDYING THE RELATIONSHIP OF SEX HORMONES DEFICIENCY AND THE APPEARANCE OF ACUTE MYOCARDIAL INFARCTION IN MEN AND WOMEN

Бейбалаева, А. М., Kudaev, M. T., Гаджиева, Т. А., Ataeva, Z. N., & Guseynova, R. K. (2022) · Современные проблемы науки и образования · doi:10.17513/spno.32057

Seguimiento de los pacientes con cardiopatía isquémica en Atención Primaria durante la pandemia por COVID-19

Larrondo, I. G., Guisado‐Clavero, M., Álvarez, M. P., Rio, L. R. D., Jurado, M. C., & Ares-Blanco, S. (2023) · Revista Clínica de Medicina de Familia · doi:10.55783/rcmf.160103

Akut Koroner Sendrom ile Başvuran Hastalarda Çoklu Damar Hastalığı Oranlarının Akut Koroner Sendrom Alt Tiplerine Göre Karşılaştırılması

Tosun, V., & Fedai, H. (2023) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1204384

Correlation analysis of cancer incidence after pravastatin treatment

Yu, J. S., Kim, R., Shinn, J., Park, M. Y., & Kim, H. (2023) · Cardiovascular Prevention and Pharmacotherapy · doi:10.36011/cpp.2023.5.e6

Clinical and genetic variants of hypertriglyceridemia in the practice of a lipidologist

KIM, Z. F., Galyavich, A. S., Sadykova, D. I., Nurieva, L. M., & Kim, S. S. (2023) · Kazan medical journal · doi:10.17816/kmj117632

Heart Failure

de Backer, T. L., & Mangoni, A. A. (2023) · Practical issues in geriatrics · doi:10.1007/978-3-031-28061-0_19

Antiatherogenic Potential of Transcranial Electrical Stimulation in a High-Fructose/High-Fat Diet: Experimental Randomized Trial

Алексеевна, Ч. Е., Каде, А. Х., Трофименко, А. И., Ким, Г. Г., & Крутова, В. А. (2023) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2023-30-3-65-75

Liver fibrosis in a comorbid patient with metabolicassociated (non-alcoholic) fatty liver disease (MAFLD-NAFLD) and cardiovascular disease

Livzan, M. A., Сергеевна, К. Т., & Syrovenko, M. I. S. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-212-4-133-139

Relationships between statins and risk reduction of aortic dissection in patients with hypertensionPreprint

Dang, Y., Li, N., Zhu, Q., Liu, S., Heizhati, M., Gan, L., Cai, X., Wen, W., Wang, M., Hu, J., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3160486/v1

The effect of achieving guideline-based target low-density lipoprotein cholesterol levels on mortality in transcatheter aortic valve implantation patients with coronary artery disease

Demir, Ö. F., & Levent, F. (2023) · The European Research Journal · doi:10.18621/eurj.1341976

Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial

Ako, J., Yokote, K., Tsujita, K., Tanigawa, R., Kamei, R., & Suganami, H. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64272

Resistencia a la insulina: sustrato fisiopatológico del síndrome metabólico

Mendoza, M. V. G., Paredes, E. G., Moya, S. M. P., Mendoza, J. P. P., & Pincay, M. S. M. (2023) · Anatomía Digital · doi:10.33262/anatomiadigital.v6i3.3.2681 · Cited by 1

2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors

Yang, Y. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.3.135

Management of Dyslipidemia in Patients with Diabetes Mellitus

Lee, K. A. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.3.111

THE RELATIONSHIP OF HYPERCHOLESTRINEMIA AND HYPERTRIGLYCERIDEMIA IN THE AZERBAIJAN POPULATION

Hajiyeva, Y. H. (2023) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm/2023.16(1).15-19

Concordance between low density lipoprotein cholesterol concentration measurement by enzymatic method and calculation by Friedewald formula in cardiovascular risk classification

Dakouri, B. Y. K., Toure, A., Hauhouot, M.-L. A., Kacou-N'douba, A., & Karamoko, I. N. (2023) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2023.038

Effect of treatment with probiotics in the reduction of altered levels of the lipid profile in humans and rats: a systematic review

Colón, A. M., Meneses-Mayo, M., & Ahuacatitan, L. L. (2023) · Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare · doi:10.36105/psrua.2023v3n6.02

Approaching cardiovascular disease in the frail patient

Baltă, M. D., Tănăsescu, R., & Piloff, L. (2023) · Medic ro · doi:10.26416/med.156.6.2023.9063

Correlation of the Dutch Lipid Clinic Network score as a diagnostic tool and lipid parameters in patients with familial hypercholesterolemia

Krstic, M., Lukač, S. S., Petakov, A., Mitrovic, M., Mišević, V., & Lalic, K. S. (2023) · Medicinski pregled · doi:10.2298/mpns2306151k

Prevalence and management of familial hypercholesterolaemia in patients with chest pain admitted to hospital: a retrospective observational study

Mülverstedt, S., Prescott, E., Jørgensen, H. S., & Heitmann, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082075

Epidemiologie und Prävention

Halle, M., & Münzel, T. F. (2024) · Springer-Lehrbuch · doi:10.1007/978-3-662-67718-6_3

Effect of Additional Prebiotics on Glycemia and Lipid Profile in Individuals with Type 2 Diabetes

Demirtaş, A. A., & Tek, N. A. (2024) · Journal of Gazi University Health Sciences Institute · doi:10.59124/guhes.1399261

Pharmacodynamic monitoring as an integral part of therapeutic drug monitoring

Langman, L. J., & Jannetto, P. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18649-3.00003-3

Score de calcio coronario: cómo, cuándo, por qué y a quién

Arostegui, N. A., Castellaccio, A., & Galván, E. V. (2024) · Revista de ecocardiografía práctica y otras técnicas de imagen cardíaca · doi:10.37615/retic.v7n2a1

Lipoprotein (a): a key factor in the pathogenesis of cardiovascular diseases

Chiruță, R. (2024) · Medic ro · doi:10.26416/med.160.4.2024.10039

EMAGRECIMENTO E HIPERTROFIA: COMPONENTES QUE ESTRUTURAM UMA BOA DIETA PARA INDIVÍDUOS COM SOBREPESO E OBESIDADE QUE BUSCAM HIPERTROFIA

Marinho, J. C. J., Filho, S. G. A., & de Lima, L. T. (2024) · Revista Contemporânea · doi:10.56083/rcv4n10-075

Assessment of metabolic markers of cardiorenal disorders in patients with arterial hypertension and metabolic syndrome

Vlasova, V. P., Александровна, С. А., & Алексеевна, М. Н. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-378

Predictors of New-Onset Atrial Fibrillation in Patients With Chronic Coronary Artery Disease After Coronary Artery Bypass Grafting: a Prospective, Observational, Single-Centre, Non-Randomized Study

Sokolova, N. Y., Savelyeva, E. A., Мартынова, К. А., Махаури, А. Д., & Меджидов, С. Р. (2024) · Kardiologiia · doi:10.18087/cardio.2024.10.n2511

Understanding the causes and consequences of low statin adherence: evidence from UK Biobank primary care dataPreprint

Türkmen, D., Liang, X., Masoli, J. A. H., Gill, D., Pilling, L. C., & Bowden, J. (2025) · medRxiv · doi:10.1101/2025.01.23.25321011

The Importance of the Harmonization and Standardization of Lipoprotein(a) Measurements

Kotani, K. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.ed279

Potential for the use of nutraceuticals for hyperlipidemia correction

Олеговна, Е. С., Zimina, P. A., Орехова, А. В., & Drapkina, O. M. (2025) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20252803140

The use of computed tomography coronary angiography for coronary heart disease diagnosis during the COVID-19 pandemic in the Voronezh Region

Khokhlov, R. A., Титова, Л. А., Lipovka, S. N., Yarmonova, M. V., Chernyshova, L. A., Yarkovaya, S. V., Polnikova, E. S., & Klimenchenko, M. (2025) · Medical Scientific Bulletin of Central Chernozemye (Naučno-medicinskij vestnik Centralʹnogo Černozemʹâ) · doi:10.18499/1990-472x-2025-26-1-15-27

Prognostic significance of high levels of lipoprotein (a) and C-reactive protein in coronary artery disease

Bansal, V., Bansal, K., & Kaur, S. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20251289

Coffee consumption as a double-edged sword for serum lipid profile: findings from NHANES 2005–2020

Mo, C.-Y., Duan, X., Pu, J., Zhou, X., Zheng, Y., & Wang, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1606188

Fatty acid profile in dorsal fat and Longissimus dorsi muscle of post-weaned hairless piglets fed with arboreal leaves meal

Moya, C. T. C., Flores, C. L., Dzib-Cauich, D. A., Oney‐Montalvo, J. E., Grageola, F., Bugarín-Prado, J. O., & Pat-Moreno, N. I. (2025) · Revista Científica de la Facultad de Ciencias Veterinarias · doi:10.52973/rcfcv-e35700

Temporal disparities in diagnosis: The critical impact of laboratory workflow inefficiencies on outcomes in metabolic and cardiovascular disorders

Dzreke, E., Dzreke, C., Asamoah, R. A., & Kanzin, D. (2025) · Advanced Research Journal · doi:10.71350/3062192585

Serotonin, 5-HIAA, and membrane serotonin transporter in blood as biomarkers of familial hypercholesterolemia in immature low-density lipoprotein receptor-deficient mice

Nigmatullina, R. R., Sadykova, D. I., Salakhova, K. R., Сластникова, Е. С., & Abzaletdinova, G. F. (2025) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2025-04-05

Low-Density-Lipoprotein Cholesterol Control and Treatment Status 1 Year after the Initial Health Checkup in Individuals with Referral-Level LDL Cholesterol

Aoki, H., Kitaoka, K., Suzuki, Y., Kaneko, H., Okada, A., Takeda, N., Morita, H., Hiroi, Y., Node, K., Furui, Y., et al. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65834

Development and external validation of a nomogram to predict the need for electrical cardioversion during radiofrequency ablation in patients with atrial fibrillation

Li, Y., Yue, X., Chen, Y., Liu, X., Wang, X., Sun, R., Li, H., Li, Q., Luo, N., Wang, F., et al. (2025) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2025.101817

Additional file 1 of Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study

Peng, J., Liu, M.-M., Liu, H.-H., Yuanlin, G., Wu, N.-Q., Dong, Q., Qian, J., Dou, K.-F., Zhu, C.-G., & Li, J.-J. (2021) · Figshare · doi:10.6084/m9.figshare.17065947

DETECTING DRUG-DRUG INTERACTIONS INDUCED BY ANTI-HYPERLIPIDEMICS: AN OBSERVATIONAL STUDY

Cengiz, Z. B., & Arslan, M. (2025) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1768327

The importance of selected laboratory parameters for the safety and performance of amateur athletes

Viczénová, D. (2025) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2025.016

The year in cardiology: Cardiovascular prevention

Ray, K. K., Laufs, U., Cosentino, F., Lobo, M. D., & Landmesser, U. (2019) · Srce i krvni sudovi · doi:10.5937/siks1904184r

Retrospective assessment of the effectiveness of lipid-lowering therapy in patients with hypertriglyceridemia in real-world clinical practice

Shomin, A. V., Serezhina, E. K., & Obrezan, A. G. (2025) · Cardiosomatics · doi:10.17816/cs685583

Coingestion of Fructose with Fat Cream Exacerbates Postprandial Lipidemia Primarily by Stimulating Endogenous Non-remnant Triglyceride Secretion

Mizutani, E., & Naito, M. (2026) · International Journal of Nutrition and Food Sciences · doi:10.11648/j.ijnfs.20261501.13

Cholesterol-lowering therapy in patients with symptomatic peripheral arterial disease – real life data in a German population

Hamers, M., Nowak, T., Böhner, H., Hummel, T., Aleksic, M., Jost, D., Winkler, M., & Geier, B. (2026) · VASA · doi:10.1024/0301-1526/a001271

The Liver-Heart Axis: A Narrative Review of Clinical Implications of the MASLD Redefinition for Internists

Abdou, H. A., & Omar, S. A. (2026) · ASIDE Gastroenterology · doi:10.71079/aside.gi.031826446

Association of traditional Chinese medicine syndromes with blood lipid profiles and cardiovascular prognosis in post-percutaneous coronary intervention atherosclerotic cardiovascular disease patients: a prospective cohort study

Huangyu, X., Qian, L., Haozhe, X., WeiDong, H., Xinyi, Z., Lu, X., Xiaoli, L., & Xinrong, F. (2026) · Digital Chinese Medicine · doi:10.1016/j.dcmed.2026.02.008

2019 European Society of Cardiology (ESC)/ European Atherosclerosis Society (EAS) Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (Russian-language short version)

(2019) · Therapy · doi:10.18565/therapy.2019.8.14-51

ESC/EAS 2019 Guidance on the Treatment of Dyslipemias: Lipid Modification to Reduce Cardiovascular Risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimón, L., Chapman, M. J., Backer, G. D., Delgado, V., Ference, B. A., et al. (2020) · Revista Española de Cardiología · Cited by 1

Editorial: 2019 European Society of Cardiology (ESC) / European Society of Atherosclerosis (EAS) Guidelines for the Management of Dyslipidaemias: Lipid Modification to reduce cardiovascular Risk

Zweiker, R. (2020) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 2

ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk

(2020) · doi:10.47407/dd2020.2.0008 · Cited by 6

Editorial-Serie: Die neuen Guidelines der ESCbr2019 European Society of Cardiology (ESC) / European Society of Atherosclerosis (EAS) Guidelines for the Management of Dyslipidaemias: Lipid Modification to reduce cardiovascular Risk

Zweiker, R. (2019) · Journal für Kardiologie (Krause & Pachernegg GmbH)